We came across a bullish thesis on CorMedix Inc. (CRMD) on Archetype Capital’s Substack. In this article, we will summarize the bulls’ thesis on CRMD. CorMedix Inc. (CRMD)'s share was trading at $14.86 as of 12th June. CRMD’s trailing and forward P/E were 59.44 and 22.88 respectively according to Yahoo Finance.
[caption id="attachment_1231089" align="aligncenter" width="768"]CorMedix offers a compelling, asymmetric investment opportunity built not on speculative biotech...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.